aid: arzeda
name: Arzeda
description: 'Arzeda Corp is a Seattle, Washington protein design company — "The Protein
  Design Company" — founded in 2008 by David Baker (2024 Nobel Prize in Chemistry),
  Alexandre Zanghellini and colleagues out of the University of Washington Institute
  for Protein Design. Its Intelligent Protein Design Technology combines physics-based
  computational protein design, generative AI and an agentic design-build-test-learn
  loop over fifteen years of proprietary in-house experimental data to create designer
  enzymes and proteins that do not exist in nature, then scale them to commercial production.
  Commercial programs span food and beverage (ViaLeaf Reb M / ProSweet Reb M stevia
  sweeteners with MANE), home and personal care enzymes (Unilever), advanced materials
  (W. L. Gore & Associates) and pharmaceutical biologics (Takeda), alongside DARPA
  and NSF funded work on AI-driven protein design and cell-free biomanufacturing. Arzeda
  co-founded the OpenFold consortium for open-source protein structure prediction.
  It sells designed molecules and joint development programs, not software, and publishes
  no public developer program, API or machine-readable interface.'
image: https://www.arzeda.com/assets/logos/arzeda_clr_wht.svg
url: https://raw.githubusercontent.com/api-evangelist/arzeda/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Synthetic Biology
- Protein Design
- Enzymes
- Artificial Intelligence
- Life Sciences
- Specialty Chemicals
- Food Ingredients
- Materials Science
- Pharmaceuticals
- Seattle
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/arzeda-domain-security.yml
- type: Website
  url: https://www.arzeda.com/
- type: About
  url: https://www.arzeda.com/about
- type: Technology
  url: https://www.arzeda.com/technology
- type: Blog
  url: https://www.arzeda.com/blog
- type: News
  url: https://www.arzeda.com/news
- type: Publications
  url: https://www.arzeda.com/publications
- type: Team
  url: https://www.arzeda.com/team
- type: Careers
  url: https://www.arzeda.com/careers
- type: Contact
  url: https://www.arzeda.com/contact
- type: GitHubOrganization
  url: https://github.com/Arzeda
- type: LinkedIn
  url: https://www.linkedin.com/company/arzeda-corp
- type: Twitter
  url: https://x.com/ArzedaCo
- type: Sitemap
  url: https://www.arzeda.com/sitemap.xml
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Arzeda sells designed enzymes, molecules and joint-development programs rather
    than software — its arzeda.com Webflow site answers every unknown path (including
    /openapi.json, /llms.txt and /.well-known/agent-card.json) with the identical 97,718-byte
    homepage soft-404, and api./docs./developer./app./platform.arzeda.com do not resolve
    in DNS at all.
  evidence:
  - url: https://www.arzeda.com/openapi.json
    status: 200
  - url: https://www.arzeda.com/definitely-not-a-real-path-xyz123
    status: 200
  - url: https://www.arzeda.com/.well-known/agent-card.json
    status: 200
  - url: https://www.arzeda.com/.well-known/security.txt
    status: 200
  - url: https://www.arzeda.com/llms.txt
    status: 200
  - url: https://api.arzeda.com/
    status: 0
  - url: https://docs.arzeda.com/
    status: 0
  - url: https://www.arzeda.com/sitemap.xml
    status: 200
  checked: '2026-08-06'